Rhabdoviridae

Industry

CPC
C07K14/145

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07KPEPTIDES C07K14/00Peptides having more than 20 amino acids Gastrins Somatostatins Melanotropins Derivatives thereof

Current Industry

C07K14/145Rhabdoviridae

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Self-inactivating rabies virus vector encoding a nucleoprotein and...
- Patent number 12,203,092
- Issue date Jan 21, 2025
- Mironid Limited
- Marco Tripodi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Attenuated strains of oncolytic rhabdovirus and uses thereof in tum...
- Patent number 11,732,012
- Issue date Aug 22, 2023
- FANTASIA BIOPHARMA (ZHEJIANG) CO. LTD.
- Frank XiaoFeng Qin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oncolytic rhabdovirus expressing IL12
- Patent number 11,590,184
- Issue date Feb 28, 2023
- TURNSTONE LIMITED PARTNERSHIP
- Almohanad Alkayyal
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for producing transgenic cell
- Patent number 11,155,833
- Issue date Oct 26, 2021
- Kaneka Corporation
- Tomoyuki Nakaishi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antiviral peptide and use therefor
- Patent number 10,745,448
- Issue date Aug 18, 2020
- Toagosei Co., Ltd.
- Tetsuhiko Yoshida
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Adjuvanted rabies vaccine with improved viscosity profile
- Patent number 9,216,213
- Issue date Dec 22, 2015
- Merial, Inc.
- Joanne L. Maki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Vaccine Compositions For Preventing Coronavirus Disease
- Publication number 20240374710
- Publication date Nov 14, 2024
- International AIDS Vaccine Initiative Inc.
- Christopher Lee Parks
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ONCOLYTIC VIRUS COMBINED WITH CAR T CELLS FOR ANTI-TUMOR THERAPY
- Publication number 20240226210
- Publication date Jul 11, 2024
- Broaden BioScience and Technology Corp.
- BUO CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SEPARATION MEDIA AND PURIFICATION METHODS FOR CARBOHYDRATE CONTAINI...
- Publication number 20240190912
- Publication date Jun 13, 2024
- Donaldson Company, Inc.
- Jinxiang Zhou
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ONCOLYTIC VIRUS COMBINED WITH CAR T CELLS FOR ANTI-TUMOR THERAPY
- Publication number 20240131096
- Publication date Apr 25, 2024
- Broaden BioScience and Technology Corp.
- BUO CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MUTATED POLYPEPTIDES, COMPOSITIONS COMPRISING THE SAME, AND USES TH...
- Publication number 20240059744
- Publication date Feb 22, 2024
- INTERIUS BIOTHERAPEUTICS, INC.
- Bruce C. Schnepp
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Vaccine Compositions For Preventing Coronavirus Disease
- Publication number 20210338804
- Publication date Nov 4, 2021
- International AIDS Vaccine Initiative Inc.
- Christopher Lee Parks
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Attenuated Strains of Oncolytic Rhabdovirus and Uses Thereof in Tum...
- Publication number 20210171583
- Publication date Jun 10, 2021
- HANGZHOU EVERBRIGHT BIOLOGICS, LTD.
- Frank XiaoFeng QIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Self-Inactivating Viral Vector
- Publication number 20210115472
- Publication date Apr 22, 2021
- United Kingdom Research and Innovation
- Marco Tripodi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PSEUDOTYPED ONCOLYTIC RHABDOVIRUSES AND THEIR USE IN COMBINATION TH...
- Publication number 20190282640
- Publication date Sep 19, 2019
- Laura Evgin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR PRODUCING TRANSGENIC CELL
- Publication number 20190271006
- Publication date Sep 5, 2019
- Kaneka Corporation
- Tomoyuki Nakaishi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ONCOLYTIC RHABDOVIRUS EXPRESSING IL12
- Publication number 20190216868
- Publication date Jul 18, 2019
- Almohanad Alkayyal
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIVIRAL PEPTIDE AND USE THEREFOR
- Publication number 20190100562
- Publication date Apr 4, 2019
- TOAGOSEI CO., LTD.
- Tetsuhiko YOSHIDA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Adjuvanted Rabies Vaccine with Improved Viscosity Profile
- Publication number 20120269846
- Publication date Oct 25, 2012
- Joanne L. Maki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Rhabdoviridae

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Self-inactivating rabies virus vector encoding a nucleoprotein and...

Attenuated strains of oncolytic rhabdovirus and uses thereof in tum...

Oncolytic rhabdovirus expressing IL12

Method for producing transgenic cell

Antiviral peptide and use therefor

Adjuvanted rabies vaccine with improved viscosity profile

Patents Applicationslast 30 patents

Vaccine Compositions For Preventing Coronavirus Disease

ONCOLYTIC VIRUS COMBINED WITH CAR T CELLS FOR ANTI-TUMOR THERAPY

SEPARATION MEDIA AND PURIFICATION METHODS FOR CARBOHYDRATE CONTAINI...

ONCOLYTIC VIRUS COMBINED WITH CAR T CELLS FOR ANTI-TUMOR THERAPY

MUTATED POLYPEPTIDES, COMPOSITIONS COMPRISING THE SAME, AND USES TH...

Vaccine Compositions For Preventing Coronavirus Disease

Attenuated Strains of Oncolytic Rhabdovirus and Uses Thereof in Tum...

Self-Inactivating Viral Vector

PSEUDOTYPED ONCOLYTIC RHABDOVIRUSES AND THEIR USE IN COMBINATION TH...

METHOD FOR PRODUCING TRANSGENIC CELL

ONCOLYTIC RHABDOVIRUS EXPRESSING IL12

ANTIVIRAL PEPTIDE AND USE THEREFOR

Adjuvanted Rabies Vaccine with Improved Viscosity Profile